TORONTO DOMINION BANK
BankPosition in SMNR — Semnur Pharmaceuticals, Inc.
CIK 947263
TORONTO, ONTARIO, A6
Position in SMNR
as of Mar 31, 2025
· filed May 15, 2025
Position Value
$0
+$0 QoQ
Shares Held
80,000
0.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SMNR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TORONTO DOMINION BANK holds $769,394,627 across 59 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
2,165,846 | $176,668,057 | |
| 2 | CELC |
Celcuity Inc.
|
1,258,758 | $131,691,261 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
3,173,258 | $103,829,001 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
181,432 | $97,419,912 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,391 | $42,416,270 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
510,253 | $32,115,323 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,783 | $30,418,151 | |
| 8 | NGNE |
Neurogene Inc.
|
681,337 | $21,428,048 |
No Holdings History
No holdings records found for this institution in SMNR.